Stroke, Acute: Clinical Trials

4 trials for Stroke, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4
Phase 22Terminated 2

Follow Stroke, Acute: new trials by email Literature Review of Stroke, Acute trials Research Report on Stroke, Acute

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maimonides Minocycline in Stroke Study
Minocycline - Stroke, Acute, Ischemic Stroke
Phase 2 / Phase 3TerminatedMaimonides Medical Center22023-11-012025-12-17
The Norwegian Tenecteplase Stroke Trial 2
Tenecteplase, Alteplase - Stroke, Acute, Cerebrovascular Disorders
Phase 3TerminatedHaukeland University Hospital2012019-10-282025-03-03
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
BIIB093, Placebo - Brain Edema, Stroke, Acute
Phase 3TerminatedRemedy Pharmaceuticals, Inc.5352018-08-292024-11-25
The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
hypothermia and anti-shivering treatment, Group1: IV t-PA and normothermia - Stroke, Acute
Phase 2 / Phase 3TerminatedUniversity of California, San Diego1202010-06-012017-04-05

Narrower conditions

Stroke (4)  ·  Cerebrovascular Disorders (3)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Ischemic Stroke (2)  ·  Vascular Diseases (2)  ·  Body Temperature Changes (1)  ·  Brain Edema (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cerebral Infarction (1)  ·  Hemorrhagic Stroke (1)  ·  Hypothermia (1)  ·  Infarction (1)

Broader conditions

Nervous System Diseases (3)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Ischemia (2)  ·  Necrosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Cerebrovascular Disorders (1)  ·  Infarction (1)

Interventions

Cool-Down Exercise (1)  ·  Glyburide (1)  ·  Minocycline (1)  ·  Tenecteplase (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Haukeland University Hospital (1)  ·  Maimonides Medical Center (1)  ·  Remedy Pharmaceuticals, Inc. (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  Switzerland (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)

Top investigators

James C. Grotta, MD (1)  ·  Patrick D. Lyden, MD (1)  ·  Thomas M. Hemmen, MD, PhD (1)

Results publications

PMID 27834742, PMID 35525250, PMID 37449423, PMID 37830342, PMID 39577921

NIH funding

2017 (1), 2018 (1), P50NS044148 (1), P50NS044227 (1)